Home/Filings/4/0001209191-21-054675
4//SEC Filing

Blickensdoerfer Hans-Martin 4

Accession 0001209191-21-054675

CIK 0000718937other

Filed

Sep 2, 8:00 PM ET

Accepted

Sep 3, 1:02 PM ET

Size

25.3 KB

Accession

0001209191-21-054675

Insider Transaction Report

Form 4
Period: 2021-09-01
Blickensdoerfer Hans-Martin
VP, International Marketing
Transactions
  • Sale

    Common Stock

    2021-09-02$157.50/sh11,038$1,738,48588,722 total
  • Exercise/Conversion

    Common Stock Options

    2021-09-0117,573871 total
    Exercise: $16.15From: 2019-03-15Exp: 2028-03-14Common Stock (17,573 underlying)
  • Exercise/Conversion

    Common Stock Options

    2021-09-0213,4840 total
    Exercise: $29.80From: 2019-06-14Exp: 2028-06-13Common Stock (13,484 underlying)
  • Sale

    Common Stock

    2021-09-01$157.61/sh8,621$1,358,75699,760 total
  • Exercise/Conversion

    Common Stock

    2021-09-01$16.15/sh+17,573$283,804117,333 total
  • Exercise/Conversion

    Common Stock

    2021-09-02$29.80/sh+13,484$401,823103,077 total
  • Sale

    Common Stock

    2021-09-02$157.50/sh17,343$2,731,52388,722 total
  • Exercise/Conversion

    Common Stock Options

    2021-09-028710 total
    Exercise: $16.15From: 2019-03-15Exp: 2028-03-14Common Stock (871 underlying)
  • Sale

    Common Stock

    2021-09-01$157.61/sh17,573$2,769,68199,760 total
  • Exercise/Conversion

    Common Stock

    2021-09-02$35.98/sh+2,988$107,508106,065 total
  • Exercise/Conversion

    Common Stock

    2021-09-02$16.15/sh+871$14,06789,593 total
  • Exercise/Conversion

    Common Stock Options

    2021-09-022,98818,140 total
    Exercise: $35.98From: 2020-03-14Exp: 2029-03-13Common Stock (2,988 underlying)
Footnotes (5)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.50 to $157.99, inclusive.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.50 to $157.99, inclusive.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.50 to $157.56, inclusive.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.50 to $157.72, inclusive.
  • [F5]The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/13/2029.

Issuer

STAAR SURGICAL CO

CIK 0000718937

Entity typeother

Related Parties

1
  • filerCIK 0001488891

Filing Metadata

Form type
4
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 1:02 PM ET
Size
25.3 KB